ITGA3 and intrahepatic cholangiocarcinoma: Similarly, in intrahepatic cholangiocarcinoma (ICC), ITGα3 overexpression is associated with adverse clinicopathological features and poor survival outcomes, further underscoring its oncogenic potential [31].